Qian He

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Chinese Academy of Sciences, Shanghai Meiyue Biotech Development Co., Ltd., Wuhan Createrna Science and Technology Co., Ltd.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qian He. Retrieved from https://idiyas.com/inventor/qian-he-6v2884zi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 75.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

2 out of 3,363

Chinese Academy of Sciences

patents

1 out of 1

Shanghai Meiyue Biotech Development Co., Ltd.

patent

1 out of 1

Wuhan Createrna Science and Technology Co., Ltd.

patent

Years Active: 2022-2026

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12617770 - IRAK inhibitor and preparation method therefor and use thereof (2026-05-05),

2. 12447136 - Use of (5R,7R,10R)-12,15-dioxo-α-selinene in the preparation of drugs (2025-10-21),

3. 11345679 - Quaternary lactam compound and pharmaceutical use thereof (2022-05-31),

4. 11214572 - 7-site substituted pyrrole triazine compounds or pharmaceutically acceptable salts thereof, and preparation method thereof and uses thereof (2022-01-04),

Title: Innovations and Contributions of Inventor Qian He

Introduction

Qian He is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating neurodegenerative diseases and thrombotic disorders. With a total of three patents to his name, Qian He continues to impact the medical research landscape.

Latest Patents

Qian He's latest patents include the use of (5R,7R,10R)-12,15-dioxo-α-selinene in the preparation of drugs. This compound, known as PFC-37, is utilized in the development of a drug aimed at preventing and treating neurodegenerative diseases, including Parkinson's disease. Another significant patent is for a quaternary lactam compound, which is used in the manufacture of a medicament for the treatment and/or prevention of thrombotic or thromboembolic disorders.

Career Highlights

Throughout his career, Qian He has worked with esteemed institutions such as the Chinese Academy of Sciences and Shanghai Meiyue Biotech Development Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to important medical innovations.

Collaborations

Qian He has collaborated with several professionals in his field, including Shanghai Yu and Yan Feng, who is a prominent female researcher. These collaborations have enriched his work and expanded the scope of his research.

Conclusion

Qian He is a distinguished inventor whose work has led to significant advancements in pharmaceutical research. His innovative patents and collaborations highlight his commitment to improving medical treatments and addressing critical health issues.

Profile summary based on public USPTO records.